Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Slow Q1 For Baxter, But Board Remains Confident Of Turnaround

Executive Summary

Baxter International recorded slight revenue increases during quarter one of 2021, with sales still impacted by COVID-19. Its board remains optimistic , pointing towards new product releases and “operational strength” as redeeming factors.

You may also be interested in...



BD Expects Alaris Infusion Pump To Return To US Market Next Year

The company stopped shipping Alaris in early 2020 after the FDA requested a new 510(k) for modifications and the device has been the subject of several recalls since then.

Digital Health Roundup, May 2021: Immersive Technologies In Surgery Suite, ‘Smart’ Toilets And Pills, New SaMD Cybersecurity Standards

In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from May.

'The Digital Pill' Author Sees Digital As Catch-All Solution For Health Care

In an interview, Elgar Fleisch, co-author of The Digital Pill, proselytized the benefits of digital health, explaining how particular innovations could solve problems in health care.

Topics

Related Companies

UsernamePublicRestriction

Register

MT143882

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel